These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2145 related articles for article (PubMed ID: 26168399)
1. Comprehensive genomic profiles of small cell lung cancer. George J; Lim JS; Jang SJ; Cun Y; Ozretić L; Kong G; Leenders F; Lu X; Fernández-Cuesta L; Bosco G; Müller C; Dahmen I; Jahchan NS; Park KS; Yang D; Karnezis AN; Vaka D; Torres A; Wang MS; Korbel JO; Menon R; Chun SM; Kim D; Wilkerson M; Hayes N; Engelmann D; Pützer B; Bos M; Michels S; Vlasic I; Seidel D; Pinther B; Schaub P; Becker C; Altmüller J; Yokota J; Kohno T; Iwakawa R; Tsuta K; Noguchi M; Muley T; Hoffmann H; Schnabel PA; Petersen I; Chen Y; Soltermann A; Tischler V; Choi CM; Kim YH; Massion PP; Zou Y; Jovanovic D; Kontic M; Wright GM; Russell PA; Solomon B; Koch I; Lindner M; Muscarella LA; la Torre A; Field JK; Jakopovic M; Knezevic J; Castaños-Vélez E; Roz L; Pastorino U; Brustugun OT; Lund-Iversen M; Thunnissen E; Köhler J; Schuler M; Botling J; Sandelin M; Sanchez-Cespedes M; Salvesen HB; Achter V; Lang U; Bogus M; Schneider PM; Zander T; Ansén S; Hallek M; Wolf J; Vingron M; Yatabe Y; Travis WD; Nürnberg P; Reinhardt C; Perner S; Heukamp L; Büttner R; Haas SA; Brambilla E; Peifer M; Sage J; Thomas RK Nature; 2015 Aug; 524(7563):47-53. PubMed ID: 26168399 [TBL] [Abstract][Full Text] [Related]
2. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas. Meder L; König K; Ozretić L; Schultheis AM; Ueckeroth F; Ade CP; Albus K; Boehm D; Rommerscheidt-Fuss U; Florin A; Buhl T; Hartmann W; Wolf J; Merkelbach-Bruse S; Eilers M; Perner S; Heukamp LC; Buettner R Int J Cancer; 2016 Feb; 138(4):927-38. PubMed ID: 26340530 [TBL] [Abstract][Full Text] [Related]
3. Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations. Ogino A; Choi J; Lin M; Wilkens MK; Calles A; Xu M; Adeni AE; Chambers ES; Capelletti M; Butaney M; Gray NS; Gokhale PC; Palakurthi S; Kirschmeier P; Oxnard GR; Sholl LM; Jänne PA Mol Oncol; 2021 Jan; 15(1):27-42. PubMed ID: 32191822 [TBL] [Abstract][Full Text] [Related]
4. Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis. Udagawa H; Umemura S; Murakami I; Mimaki S; Makinoshima H; Ishii G; Miyoshi T; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuchihara K; Goto K Lung Cancer; 2018 Dec; 126():182-188. PubMed ID: 30527185 [TBL] [Abstract][Full Text] [Related]
5. Clinical correlation of extensive-stage small-cell lung cancer genomics. Dowlati A; Lipka MB; McColl K; Dabir S; Behtaj M; Kresak A; Miron A; Yang M; Sharma N; Fu P; Wildey G Ann Oncol; 2016 Apr; 27(4):642-7. PubMed ID: 26802149 [TBL] [Abstract][Full Text] [Related]
6. Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes. Offin M; Chan JM; Tenet M; Rizvi HA; Shen R; Riely GJ; Rekhtman N; Daneshbod Y; Quintanal-Villalonga A; Penson A; Hellmann MD; Arcila ME; Ladanyi M; Pe'er D; Kris MG; Rudin CM; Yu HA J Thorac Oncol; 2019 Oct; 14(10):1784-1793. PubMed ID: 31228622 [TBL] [Abstract][Full Text] [Related]
7. FGFR1 Oncogenic Activation Reveals an Alternative Cell of Origin of SCLC in Rb1/p53 Mice. Ferone G; Song JY; Krijgsman O; van der Vliet J; Cozijnsen M; Semenova EA; Adams DJ; Peeper D; Berns A Cell Rep; 2020 Mar; 30(11):3837-3850.e3. PubMed ID: 32187553 [TBL] [Abstract][Full Text] [Related]
8. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Peifer M; Fernández-Cuesta L; Sos ML; George J; Seidel D; Kasper LH; Plenker D; Leenders F; Sun R; Zander T; Menon R; Koker M; Dahmen I; Müller C; Di Cerbo V; Schildhaus HU; Altmüller J; Baessmann I; Becker C; de Wilde B; Vandesompele J; Böhm D; Ansén S; Gabler F; Wilkening I; Heynck S; Heuckmann JM; Lu X; Carter SL; Cibulskis K; Banerji S; Getz G; Park KS; Rauh D; Grütter C; Fischer M; Pasqualucci L; Wright G; Wainer Z; Russell P; Petersen I; Chen Y; Stoelben E; Ludwig C; Schnabel P; Hoffmann H; Muley T; Brockmann M; Engel-Riedel W; Muscarella LA; Fazio VM; Groen H; Timens W; Sietsma H; Thunnissen E; Smit E; Heideman DA; Snijders PJ; Cappuzzo F; Ligorio C; Damiani S; Field J; Solberg S; Brustugun OT; Lund-Iversen M; Sänger J; Clement JH; Soltermann A; Moch H; Weder W; Solomon B; Soria JC; Validire P; Besse B; Brambilla E; Brambilla C; Lantuejoul S; Lorimier P; Schneider PM; Hallek M; Pao W; Meyerson M; Sage J; Shendure J; Schneider R; Büttner R; Wolf J; Nürnberg P; Perner S; Heukamp LC; Brindle PK; Haas S; Thomas RK Nat Genet; 2012 Oct; 44(10):1104-10. PubMed ID: 22941188 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer. Lin MW; Su KY; Su TJ; Chang CC; Lin JW; Lee YH; Yu SL; Chen JS; Hsieh MS Lung Cancer; 2018 Nov; 125():282-290. PubMed ID: 30429033 [TBL] [Abstract][Full Text] [Related]
10. Small-cell lung cancer: what we know, what we need to know and the path forward. Gazdar AF; Bunn PA; Minna JD Nat Rev Cancer; 2017 Dec; 17(12):725-737. PubMed ID: 29077690 [TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma Expression and Targeting by CDK4/6 Inhibitors in Small Cell Lung Cancer. Wildey G; Shay AM; McColl KS; Yoon S; Shatat MA; Perwez A; Spainhower KB; Kresak AM; Lipka M; Yang M; Behtaj M; Fu P; Alahmadi A; Mneimneh W; Abbas A; Dowlati A Mol Cancer Ther; 2023 Feb; 22(2):264-273. PubMed ID: 36399634 [TBL] [Abstract][Full Text] [Related]
13. Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung Cancer. Hong D; Knelson EH; Li Y; Durmaz YT; Gao W; Walton E; Vajdi A; Thai T; Sticco-Ivins M; Sabet AH; Jones KL; Schinzel AC; Bronson RT; Nguyen QD; Tolstorukov MY; Vivero M; Signoretti S; Barbie DA; Oser MG Cancer Res; 2022 Jan; 82(2):248-263. PubMed ID: 34810201 [TBL] [Abstract][Full Text] [Related]
14. Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. Schaffer BE; Park KS; Yiu G; Conklin JF; Lin C; Burkhart DL; Karnezis AN; Sweet-Cordero EA; Sage J Cancer Res; 2010 May; 70(10):3877-83. PubMed ID: 20406986 [TBL] [Abstract][Full Text] [Related]
15. Targeted Inhibition of the E3 Ligase SCF Zhao H; Iqbal NJ; Sukrithan V; Nicholas C; Xue Y; Yu C; Locker J; Zou J; Schwartz EL; Zhu L Cancer Res; 2020 Jun; 80(11):2355-2367. PubMed ID: 32265224 [TBL] [Abstract][Full Text] [Related]